| Jan'20 | Jan'19 | Jan'18 | Jan'17 | |||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss | ||||||
-83,394 | -72,741 | -39,377 | -39,098 | |||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Depreciation, amortization and accretion | ||||||
11,866 | 8,228 | 6,550 | 4,551 | |||
Stock-based compensation | ||||||
45,046 | 25,357 | 8,990 | 4,383 | |||
Provision for doubtful accounts | ||||||
3,887 | 3,949 | 3,306 | 3,095 | |||
Other | ||||||
- | - | - | 0 | |||
Donation of common stock to charitable foundation | ||||||
0 | 1,000 | 0 | 0 | |||
Amortization of deferred commissions | ||||||
9,500 | 8,000 | 6,100 | - | |||
Reduction in carrying amount of right-of-use assets | ||||||
8,584 | 0 | 0 | - | |||
Other | ||||||
1,643 | 147 | 0 | 0 | |||
Changes in operating assets and liabilities: | ||||||
Accounts receivable | ||||||
14,504 | 12,443 | 20,983 | 7,562 | |||
Prepaid expenses and other assets | ||||||
4,180 | 5,825 | 3,194 | 1,099 | |||
Deferred commissions | ||||||
11,411 | 13,556 | 11,137 | - | |||
Other assets | ||||||
- | - | - | 0 | |||
Accounts payable | ||||||
417 | -1,103 | -3,774 | -428 | |||
Accrued expenses and other liabilities | ||||||
627 | 5,856 | 4,387 | -25 | |||
Accrued employee liabilities | ||||||
1,590 | 4,902 | 6,371 | 3,304 | |||
Deferred revenue | ||||||
25,522 | 24,689 | 17,967 | 7,904 | |||
Operating lease liabilities | ||||||
1,202 | 0 | 0 | - | |||
Other long-term liabilities | ||||||
- | - | - | 0 | |||
Net cash used in operating activities | ||||||
-3,590 | -23,581 | -24,776 | -24,975 | |||
Cash flows from investing activities: | ||||||
Purchases of property and equipment | ||||||
21,424 | 13,412 | 4,698 | 3,776 | |||
Releases of deposits, net | ||||||
- | - | - | 91 | |||
Purchases of short-term investments | ||||||
184,633 | 107,464 | 0 | 0 | |||
Sales of short-term investments | ||||||
3,497 | 0 | 0 | - | |||
Maturities of short-term investments | ||||||
172,800 | 0 | 0 | - | |||
Business combination, net of cash acquired | ||||||
0 | 247 | 11,420 | 0 | |||
Net cash used in investing activities | ||||||
-29,760 | -121,123 | -16,118 | -3,685 | |||
Cash flows from financing activities: | ||||||
Payments under capital leases | ||||||
0 | 3,623 | 2,081 | 1,982 | |||
Proceeds from issuance of common stock upon exercise of stock options | ||||||
12,079 | 11,481 | 4,453 | 1,621 | |||
Repurchases of unvested common stock | ||||||
119 | 18 | 2 | 67 | |||
Payments of offering costs | ||||||
0 | 4,399 | 643 | 0 | |||
Proceeds of issuance of common stock under employee stock purchase plan | ||||||
8,980 | 5,329 | 0 | 0 | |||
Proceeds from initial public offering, net of underwriters’ discounts and commissions | ||||||
0 | 164,703 | 0 | 0 | |||
Payments under related party notes receivable | ||||||
0 | 4,344 | 1,281 | 0 | |||
Repayments of related party notes receivable | ||||||
0 | 5,625 | 0 | 0 | |||
Principal payments on long-term debt | ||||||
2,960 | 834 | 0 | - | |||
Principal payments on long-term debt | ||||||
- | - | - | 0 | |||
Payments related to business combination | ||||||
0 | 12,558 | 0 | 0 | |||
Proceeds from long-term debt, net of issuance costs | ||||||
0 | 0 | 14,969 | 0 | |||
Net cash provided by financing activities | ||||||
17,980 | 161,362 | 15,415 | -428 | |||
Effect of exchange rates on cash and cash equivalents and restricted cash | ||||||
-379 | 3 | 960 | -470 | |||
Net (decrease) increase in cash and cash equivalents and restricted cash | ||||||
-15,749 | 16,661 | -24,519 | -29,558 | |||
Supplemental disclosure of cash flow information: | ||||||
Cash paid for interest | ||||||
595 | 963 | 421 | 160 | |||
Cash paid for tax | ||||||
836 | 755 | 952 | 402 | |||
Supplemental disclosure of non-cash investing and financing activities: | ||||||
Property and equipment acquired under capital leases | ||||||
0 | 0 | 644 | 1,264 | |||
Lapse in restrictions on early exercised common stock options | ||||||
412 | 2,088 | 734 | 731 | |||
Property and equipment purchases accrued or in accounts payable | ||||||
3,611 | 307 | 171 | 16 | |||
Deferred offering costs payable or accrued but not paid | ||||||
0 | 210 | 1,817 | 0 | |||
Accrued acquisition-related payments | ||||||
0 | 0 | 12,558 | 0 | |||
Accrued interest on related party notes receivable | ||||||
0 | 0 | 5 | 0 | |||